Migraine prevention in the real world: Exploring the role of anti-CGRP antibodies Online course Access the 4 module course on Migraine, dealing with topics including innovative treatments (Anti-CGRP), patient’s perspective and key updates on the field.
Anti-CGRP Migraine Read More »
Webinar with Gamian Europe: Migraine and Mental Health Addressing the Challenge On 21st September, 11:00 CET, join us for our webinar: “Migraine and Mental Health: Addressing the Challenge.” Discover how migraines intersect with mental health issues, particularly in women. The webinar is a collaborative initiative between GAMIAN-Europe and the European Migraine and Headache Alliance. During
Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: Research Subanesthetic ketamine infusion has been used for managing refractory headache in inpatient or outpatient infusion settings. Intranasal ketamine may be an alternative option for outpatient care. Methods A retrospective study was conducted at a single tertiary headache center to assess the clinical
Intranasal ketamine for chronic migraine Read More »
At EMHA, we believe that the health and wellbeing of employees is paramount to their success in the workplace. That’s why we were proud to co-host a conference with BBVA that centered on health and emotional management. Our esteemed guest, Professor Peter Goadsby from King’s College London, provided valuable insights on migraines and how to
EMHA and Prof. Peter Goadsby at BBVA. Read More »
My migraines are a super power By Harris A. Eyre MD PhD “You may encounter many defeats, but you must not be defeated. In fact, it may be necessary to encounter the defeats so you can know who you are, what you can rise from, and how you can still come out of it.” —
My migraines are a super power Read More »
Managing Migraine at work Is it possible to create a safe and inclusive workplace for managing Migraine at work?Yes, it is. Companies need to be aware that an environment that meets the specific needs of those suffering from invisible diseases can become a facilitator and that it is necessary to apply design criteria that reduce
Managing Migraine at work Read More »
Messoud Ashina MD PhD DMsc is Professor of Neurology, Danish Headache Center and Department of Neurology, University of Copenhagen, and has been involved into headache research since 1995. He completed his PhD in headache science focusing on tension-type headaches. Since 2006, he has been working on migraine and, in particular, experimental models of migraine. We had the
Meet the Expert: Messoud Ashina Read More »
The Access to Care event: Spain Undervalued, underdiagnosed and undertreated.These words aptly describe the reality of a disabling neurological disease that affects over five million people in Spain: migraine. This type of primary headache causes recurring bouts of moderate or intense pain that may be accompanied by nausea, vomiting or extreme sensitivity to light, sound
Access to care: Spain Read More »
The Access to care: Czech Republic event. Migraine is one of the most common neurological diseases. Nevertheless, it is underestimated and still underdiagnosed and undertreated throughout Europe. Patients who struggle with this disease are subsequently limited in their personal and professional lives, which has, among other things, a secondary social and economic impact on them.
Access to care: Czech Republic Read More »
MTIS 2022: September is a busy month for #MigraineAdvocacy The past weekend, the EMHA was part of the MTIS event, organized by The Migraine Trust, giving voice to all migraine sufferers around Europe. Watch the Opening Ceremony here: We also asked the visitors to sit on the chairs to raise awareness on the time to
Don't miss out on any updates! Join our community and discover
the latest research, treatments, and events on migraine.
Subscribe now!
